Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages
Authors:
Open Access
- 5 August 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7, 407
Abstract
Objective: This study aimed to obtain a comprehensive overview on the perception, attitudes, and experience of European pharmacists with prospective risk assessment procedures in everyday practice, as well as to identify challenges and solutions. This is a follow-up study to the surveys on prospective risk assessment previously carried out within the COST Action 15105 among pharmacists across Europe. Methodology: In-depth interviews were performed using an interview guide comprising 25 questions. Interviews were transcribed ad verbatim and imported into NVivo 10 for framework analysis. In NVivo, the interviews were coded through assigning text segments to a responding code from a coding tree, covering the full content of the interviews. Coded text segments were then charted into a matrix, and analyzed by interpreting all text segments per code. Results: In total, 18 interviews were conducted. From the framework analysis, 6 codes and 12 sub-codes emerged. Overall, despite citing specific issues pertaining to its implementation, the interviewees considered multi-stakeholder and multi-disciplinary prospective risk assessment to be essential. While healthcare professionals reported being aware of the importance of risk assessment, they cited insufficient knowledge and skills to be a major obstacle in everyday practice. They also reported inadequate IT support since a paper-based system is still widely in use, thereby complicating data extraction to carry out prospective risk assessment. Conclusion: While prospective risk assessment was found to be valuable, interviewees also found it to be a resource-intensive and time-consuming process. Due to resource constraints, it may not be possible or desirable to conduct prospective risk assessment for every shortage. However, for critical-essential drugs, it is crucial to have a ready-to-use substitute based on risk assessment. Moreover, potential risks of substitutes on patient health should be identified before a shortage occurs and the substitute is dispensed as an alternative.Keywords
This publication has 48 references indexed in Scilit:
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- Drug shortages in Canadian anesthesia: a national surveyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2013
- Promoting a Culture of Safety as a Patient Safety StrategyAnnals of Internal Medicine, 2013
- Antimicrobial Drug Shortages: A Crisis Amidst the Epidemic and the Need for Antimicrobial Stewardship Efforts to Lessen the EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Exploring Relationships Between Hospital Patient Safety Culture and Adverse EventsJournal of Patient Safety, 2010
- ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health SystemsAmerican Journal of Health-System Pharmacy, 2009
- A Risk Analysis Method to Evaluate the Impact of a Computerized Provider Order Entry System on Patient SafetyJournal of the American Medical Informatics Association, 2008
- Healthcare climate: A framework for measuring and improving patient safety*Critical Care Medicine, 2007
- Guidelines for Therapeutic Interchange—2004: American College of Clinical PharmacyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutionsQuality and Safety in Health Care, 2005